Postmortem magnetic resonance imaging of the heart ex situ: development of technical protocols
- 367 Downloads
Postmortem MRI (PMMR) examinations are seldom performed in legal medicine due to long examination times, unfamiliarity with the technique, and high costs. Furthermore, it is difficult to obtain access to an MRI device used for patients in clinical settings to image an entire human body. An alternative is available: ex situ organ examination. To our knowledge, there is no standardized protocol that includes ex situ organ preparation and scanning parameters for postmortem MRI. Thus, our objective was to develop a standard procedure for ex situ heart PMMR examinations. We also tested the oily contrast agent Angiofil® commonly used for PMCT angiography, for its applicability in MRI. We worked with a 3 Tesla MRI device and 32-channel head coils. Twelve porcine hearts were used to test different materials to find the best way to prepare and place organs in the device and to test scanning parameters. For coronary MR angiography, we tested different mixtures of Angiofil® and different injection materials. In a second step, 17 human hearts were examined to test the procedure and its applicability to human organs. We established two standardized protocols: one for preparation of the heart and another for scanning parameters based on experience in clinical practice. The established protocols enabled a standardized technical procedure with comparable radiological images, allowing for easy radiological reading. The performance of coronary MR angiography enabled detailed coronary assessment and revealed the utility of Angiofil® as a contrast agent for PMMR. Our simple, reproducible method for performing heart examinations ex situ yields high quality images and visualization of the coronary arteries.
KeywordsPostmortem MRI Contrast agent Coronary MR angiography Ex situ heart Protocol
One of the authors (SG) has personal research funding from the Fondation Leenaards, Lausanne, Switzerland.
The contrast agent Angiofil® was provided for this study by the Swiss Company Fumedica AG.
The authors thank Mr Pascal Chèvre, radiographer deputy chief of the MRI unit of the Service of Diagnostic and Interventional Radiology form the University Hospital Lausanne, and Bruno Bonet, radiographer in the Brain Behaviour Laboratory of the University of Geneva, for their appreciated help.
Conflict of interests
None of the authors have any conflicts of interest to declare.
- 7.Amano Y, Tachi M, Tani H, Mizuno K, Kobayashi Y, Kumita S(2012) T2-weighted cardiac magnetic resonance imaging of edema in myocardial diseases. Scientific World Journal 194069Google Scholar
- 16.Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123:933–944CrossRefPubMedGoogle Scholar
- 18.Anonymous (2000) Recommendation no R(99)3 of the committee of ministers to member states on the harmonization of medico-legal autopsy rules. Council of Europe, Committee of Ministers. Adopted by the Committee of Ministers on 2 February 1999 at the 658th meeting of the Ministers’ DeputiesGoogle Scholar
- 21.Kellman P, Mancini C, Vasu S, Leung SW, Wilson JR, Shanbhag SM, Chen MY, Arai AE (2012) MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. Cardiovasc Magn Reson 14:83CrossRefGoogle Scholar
- 27.Grabherr S, Grimm J, Dominguez A, Vanhaebost J, Mangin P (2014) Advances in post-mortem CT-angiography. Br J Radiol Jan 7 [Epub ahead of print]Google Scholar